Boehringer Ingelheim and Takeda are the only two pharmaceutical ... companies that enrich the workplace environment. Run by the Netherlands-headquartered Top Employers Institute, the annual ...

A trial ended with a hung jury on Thursday in a California man's lawsuit alleging Boehringer Ingelheim's discontinued heartburn drug Zantac gave him bladder cancer. Latest Zantac trial against ...

During the conversation with GEN, He highlighted several investments that Boehringer Ingelheim has made in AI-based tech. About a year ago, the company announced a multi-target drug discovery ...

Nov 22 (Reuters) - A trial ended with a hung jury on Thursday in a California man's lawsuit alleging Boehringer Ingelheim's discontinued heartburn drug Zantac gave him bladder cancer. The jury in ...

Boehringer Ingelheim has launched EURICAN® L4, a new vaccine designed to protect dogs from leptospirosis, a potentially fatal disease spread thr ...